News | August 10, 2023
Abbott India's Q1 FY24 PAT up at Rs. 290.24 Cr
Abbott India has reported total income of Rs. 1535 crores during the period ended June 30, 2023
Abbott India has reported total income of Rs. 1535 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1392.72 crores during the period ended March 31, 2023
The study concluded that elevated levels of two proteins help predict how a person will recover from a traumatic brain injury (TBI), providing important information to determine appropriate care
Abbott's multiplex test runs on its most advanced molecular PCR platform, the Alinity m system, which provides fast results in high volumes – detecting four infections simultaneously
New expanded indication provides patients suffering from earlier stages of heart failure access to the CardioMEMS HF System, a small implantable sensor that can flag early warning signs of worsening heart failure
Recall does not include any metabolic deficiency nutrition formulas
Proprietary implant-to-implant (i2i) device technology is used for communication between two implanted leadless pacemakers to regulate the heart rate
PPH is associated with almost 20 per cent of maternal mortality in India
PAT rises to Rs 195.76 crore
Ultreon 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using AI -
Subscribe To Our Newsletter & Stay Updated
